Advertisement
Journal Home
Search for

Volume 64, Issue 2, Pages 160-165 (May 2009)


View previous. 7 of 22 View next.

Clinicopathological analysis of primary lung carcinoma with heterotopic ossification

Hidehiko Kuribayashiac, Koji TsutaaCorresponding Author Informationemail address, Eiki Mizutaniab, Akiko Miyagi Maeshimaa, Yukihiro Yoshidab, Akihiko Gemmac, Shoji Kudohc, Hisao Asamurab, Yoshihiro Matsunoa

Received 26 May 2008; received in revised form 23 July 2008; accepted 2 August 2008. published online 26 September 2008.

Abstract 

Pulmonary heterotopic ossification is an unusual event. The relationship between ossification and lung carcinoma is unclear. The present study analyzed clinicopathological features of primary lung carcinoma with heterotopic ossification. We reviewed 2269 surgically resected primary lung carcinomas and identified 33 with heterotopic ossification, including 15 cases with intratumoral heterotopic ossification (IHO) and 18 cases with extratumoral heterotopic ossification (EHO). All cases with IHO were adenocarcinomas and 10 of 15 (66.6%) cases had confirmed positive mucin staining in the tumor cells. Cases with EHO could be divided into three patterns, and each pattern is potentially associated with the background conditions of lung parenchyma. Immunohistochemistry, BMP-2 production was present in 13 of 15 (86.7%) cases with IHO, although, only 4 of 17 (23.5%) cases with EHO. A prognostic analysis revealed no statistically significant difference to be observed between adenocarcinomas with IHO and without IHO. The present study suggested that IHO associated with adenocarcinomas and BMP-2 production in the tumor cells, whereas EHO was not associated with the biology of the carcinoma.

a Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan

b Thoracic Surgery Division, National Cancer Center Hospital, Tokyo, Japan

c Department of Internal Medicine, Division of Pulmonary Medicine, Infectious Diseases, and Oncology, Nippon Medical School, Tokyo, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 3 3542 2511; fax: +81 3 3545 3567.

PII: S0169-5002(08)00421-2

doi:10.1016/j.lungcan.2008.08.007


View previous. 7 of 22 View next.